Heritable immunization of the white-footed mouse reservoir of Lyme disease
白足小鼠莱姆病储库的遗传免疫
基本信息
- 批准号:9989482
- 负责人:
- 金额:$ 95.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAlbuminsAllelesAnimal ModelAnimalsAntibodiesAreaB-LymphocytesBackBindingBorrelia burgdorferiCell LineCell Surface ProteinsChromosomal translocationCommunitiesDeerDisadvantagedDiseaseDisease ReservoirsES Cell LineElementsEngineeringEnterobacteria phage P1 Cre recombinaseEnvironmentEpitopesFeedbackGene Transfer TechniquesGenesGeographyGoalsHeritabilityImmunityImmunizationImmunizeImmunoglobulin Variable RegionIn VitroIncidenceIndividualInterventionInvestmentsLightLinkLiverLyme DiseaseMembrane ProteinsMethodsMidwestern United StatesMusMutationOspA proteinPlayPopulationPreventionPrevention strategyProductionProtective ClothingReciprocal TranslocationRecombinantsResearch PersonnelResistanceRiskRoleSystemTestingTick-Borne DiseasesTicksTimeTransgenesTransgenic OrganismsVaccinatedWhite-Footed MouseWorkZoonosesacaricideantibody testcostdisease transmissionembryonic stem cellexposed human populationfield studyfitnessin vitro activityin vivointerestpathogenpreventresistance genetransmission processunderdominance
项目摘要
Project Summary RFA-AI-19-037
The rising incidence of Lyme disease demands new strategies for prevention. Existing methods
such as acaricides, deer reduction, landscaping, and personal protective clothing, are inherently
short-term and must be regularly re-applied, maintained and worn. The Mice Against Ticks
project seeks to develop a durable one-time intervention to disrupt the ecological
cycle of Lyme disease transmission for many decades. The causative agent of Lyme
disease B. burgdorferi is passed back and forth between ticks and their small animal hosts,
which serve as zoonotic reservoirs of disease. The white-footed mouse P. leucopus is widely
considered to be the most important reservoir because it is both ubiquitous and extremely
efficient at acquiring and transmitting pathogens via ticks. Our overarching goal for this
proposed project is to heritably immunize white-footed mice against Lyme by encoding
protective P. leucopus antibodies targeting B. burgdorferi outer surface protein A (OspA) in the
mouse germline. According to our calculations, combining at least four such antibodies should
prevent evolutionary escape by B. burgdorferi because too many simultaneous OspA mutations
would be needed. Crucially, even if these mice are less important in some areas than currently
thought, immunization will reduce the number of infected ticks, which in turn will infect fewer
secondary reservoirs, which will infect fewer ticks, reinforcing a negative feedback spiral
anticipated to greatly reduce the local burden of Lyme disease. We have already successfully
isolated anti-OspA antibodies from OspA-immunized P. leucopus, derived putative P. leucopus
embryonic stem cells, and shown that the albumin locus appears suitable for antibody secretion
from the liver. We now seek to (1) identify antibodies that bind to at least four different OspA
epitopes, (2) establish a stable embryonic stem cell line and perform germline editing, and (3)
generate heritably resistant mice that express antibodies from a cisgenic cassette linked to a
reciprocal chromosomal translocation, a naturally occurring form of high-threshold gene drive
that would enable the reversible and tightly localized engineering of wild P. leucopus
populations. Our open and community-guided approach has met with apparent enthusiasm by
residents of Nantucket and Martha’s Vineyard, indicating that local communities suffering from
tick-borne disease throughout the Northeast and Upper Midwest may wish to immunize their
own wild mouse populations in order to help prevent Lyme disease for many decades.
项目摘要RFA-AI-19-037
莱姆病发病率的上升需要新的预防策略。
例如杀螨剂、减少鹿、景观美化和个人防护服等,本质上是
短期有效,必须定期重新使用、维护和佩戴。
该项目旨在开发一种持久的一次性干预措施来破坏生态
莱姆病的传播周期长达数十年莱姆病的病原体
伯氏疏螺旋体疾病在蜱虫和小动物宿主之间来回传播,
作为人畜共患疾病的宿主,白足小鼠P.
被认为是最重要的水库,因为它无处不在且极为重要
我们的首要目标是通过蜱虫有效获取和传播病原体。
拟议的项目是通过编码对白足小鼠进行遗传性免疫莱姆病
针对伯氏疏螺旋体外表面蛋白 A (OspA) 的保护性P。
根据我们的计算,结合至少四种这样的抗体应该。
防止伯氏疏螺旋体的进化逃逸,因为同时发生太多 OspA 突变
至关重要的是,即使这些小鼠在某些领域的重要性不如目前。
人们认为,免疫接种会减少受感染蜱虫的数量,从而减少感染蜱虫的数量
次要宿主,将感染更少的蜱虫,强化负反馈螺旋
预计将大大减轻莱姆病的当地负担,我们已经成功地做到了这一点。
从 OspA 免疫的白细胞中分离出抗 OspA 抗体,源自假定的白细胞。
胚胎干细胞,并表明白蛋白位点似乎适合抗体分泌
我们现在寻求 (1) 鉴定与至少四种不同的 OspA 结合的抗体。
表位,(2) 建立稳定的胚胎干细胞系并进行种系编辑,以及 (3)
产生具有遗传抗性的小鼠,这些小鼠表达来自与连接的顺基因盒的抗体
染色体相互易位,高阈值基因驱动的自然发生形式
这将使野生 leucopus 的可逆和紧密定位工程成为可能。
我们的开放和社区引导的方法受到了人们的明显热情。
楠塔基特岛和玛莎葡萄园岛的居民,表明当地社区遭受
整个东北部和中西部北部地区的蜱传疾病可能希望对其进行免疫接种
几十年来,我们一直在饲养自己的野生老鼠,以帮助预防莱姆病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin Esvelt其他文献
Kevin Esvelt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin Esvelt', 18)}}的其他基金
Heritable immunization of the white-footed mouse reservoir of Lyme disease
白足小鼠莱姆病储库的遗传免疫
- 批准号:
10677804 - 财政年份:2021
- 资助金额:
$ 95.75万 - 项目类别:
Heritable immunization of the white-footed mouse reservoir of Lyme disease
白足小鼠莱姆病储库的遗传免疫
- 批准号:
10674208 - 财政年份:2021
- 资助金额:
$ 95.75万 - 项目类别:
EVOLVING VIRUS-SPECIFIC sACE2 MIMICS FOR COMPETITIVE INHIBITION OF SARS-CoV-2
进化病毒特异性 sACE2 模拟物以竞争性抑制 SARS-CoV-2
- 批准号:
10175307 - 财政年份:2020
- 资助金额:
$ 95.75万 - 项目类别:
Developing powerful daisy drive systems for the precise alteration of local populations
开发强大的雏菊驱动系统以精确改变当地人口
- 批准号:
10085329 - 财政年份:2017
- 资助金额:
$ 95.75万 - 项目类别:
Sculpting the Enteric Microbiota with CRISPR-Cas Systems
使用 CRISPR-Cas 系统塑造肠道微生物群
- 批准号:
9198068 - 财政年份:2016
- 资助金额:
$ 95.75万 - 项目类别:
Sculpting the Enteric Microbiota with CRISPR-Cas Systems
使用 CRISPR-Cas 系统塑造肠道微生物群
- 批准号:
9267984 - 财政年份:2016
- 资助金额:
$ 95.75万 - 项目类别:
Sculpting the Enteric Microbiota with CRISPR-Cas Systems
使用 CRISPR-Cas 系统塑造肠道微生物群
- 批准号:
8751445 - 财政年份:2014
- 资助金额:
$ 95.75万 - 项目类别:
相似国自然基金
用于胰腺癌光免疫协同治疗的单分子白蛋白纳米粒及其增敏机制研究
- 批准号:32330060
- 批准年份:2023
- 资助金额:212 万元
- 项目类别:重点项目
光开关、光动力药物/白蛋白超分子体系的构筑及可控能量传递性能研究
- 批准号:22371012
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
巯基介导的花色苷/豌豆白蛋白递送体系与肠道粘蛋白MUC2的粘附作用机制研究
- 批准号:32372360
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大豆肽调控白蛋白程序化代谢的吸收界面及构效机制研究
- 批准号:32372317
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
小白蛋白调控巨噬细胞极化改善泌乳素瘤耐药的机制研究
- 批准号:82373131
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Genetic modifiers of Sickle Cell Kidney Disease
镰状细胞性肾病的基因修饰
- 批准号:
10370914 - 财政年份:2022
- 资助金额:
$ 95.75万 - 项目类别:
Genetic modifiers of Sickle Cell Kidney Disease
镰状细胞性肾病的基因修饰
- 批准号:
10557196 - 财政年份:2022
- 资助金额:
$ 95.75万 - 项目类别:
Optimized Gene Replacement for AAT deficiency and Modeling of Clinical Outcomes in small and large animal models
针对 AAT 缺陷的优化基因替换以及小型和大型动物模型中的临床结果建模
- 批准号:
10674943 - 财政年份:2021
- 资助金额:
$ 95.75万 - 项目类别:
Role of LSD1 in Hypertension and Renal Injury in Blacks
LSD1 在黑人高血压和肾损伤中的作用
- 批准号:
10686277 - 财政年份:2021
- 资助金额:
$ 95.75万 - 项目类别:
Optimized Gene Replacement for AAT deficiency and Modeling of Clinical Outcomes in small and large animal models
针对 AAT 缺陷的优化基因替换以及小型和大型动物模型中的临床结果建模
- 批准号:
10270092 - 财政年份:2021
- 资助金额:
$ 95.75万 - 项目类别: